Opus Genetics to present OPGx-BEST1 Cohort 1 topline data
Topline Phase 1/2 Cohort 1 data from the OPGx-BEST1 gene therapy program will be presented on Sept. 9 at 8:00 a.m. ET in an investor webcast and conference call.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.